key: cord-0957032-9gkko3lu
authors: Benson‐Pope, Samantha Jane; Gearry, Richard B.
title: Editorial: increasing IBD prevalence and its complications in the context of the COVID‐19 pandemic
date: 2020-05-14
journal: Aliment Pharmacol Ther
DOI: 10.1111/apt.15759
sha: 460832b6ce69001451820c86337281b36bf190ed
doc_id: 957032
cord_uid: 9gkko3lu

LINKED CONTENT This article is linked to King et al papers. To view these articles, visit https://doi.org/10.1111/apt.15701 and https://doi.org/10.1111/apt.15769.

Historically, the association between IBD and colorectal cancer has been a major focus of risk management and patient care. 2 In their paper, ing challenges facing IBD clinicians in the future. First, we will continue to see more IBD as the prevalence increases worldwide. This will require improved management strategies to provide high-quality care to more patients. Second, complications of the disease and its treatment, be they established or evolving will require individualised approaches.

While some planning will be needed to mitigate these, working together at times of crisis will enable the best results for our patients.

Declaration of personal interests: Richard Gearry has served as a speaker, a consultant and an advisory board member for AbbVie and Zespri International, and has received research funding from Zespri

International. 

Changing patterns in the epidemiology and outcomes of inflammatory bowel disease in the United Kingdom

Risk of colorectal cancer in inflammatory bowel diseases

Systematic review with meta-analysis: biologics and risk of infection or cancer in elderly patients with inflammatory bowel disease

The incidence of cancer and mortality in paediatric onset inflammatory bowel disease in Denmark and Finland during a 23-year period: a population-based study

The risk of venous thromboembolism during and after hospitalisation in patients with inflammatory bowel disease activity

Predictors for developing intestinal failure in patients with Crohn's disease

Current data

Protection of 318 inflammatory bowel disease patients from the outbreak and rapid spread of COVID-19 infection in Wuhan, China. SSRN Electron J [Internet

Crohn's disease or COVID-19 ulcerative colitisIOIBD

Inflammatory bowel disease care in the COVID-19 pandemic era: the Humanitas, Milan experience

This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.